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Abstract
1,2-Cyclohexane dicarboxylic acid, diisononyl ester (DINCH) is a complex mixture of nine 
carbon branched-chain isomers. It has been used in Europe since 2002 as a plasticizer to replace 
phthalates such as di(2-ethylhexyl)phthalate (DEHP) and diisononyl phthalate (DINP). Urinary 
concentrations of the oxidative metabolites of DINCH, namely cyclohexane-1,2-dicarboxylic acid-
monocarboxy isooctyl ester (MCOCH); cyclohexane-1,2-dicarboxylic acid-mono(oxo-isononyl) 
ester (MONCH); and cyclohexane-1,2-dicarboxylic acid-mono(hydroxy-isononyl) ester 
(MHNCH), can potentially be used as DINCH exposure biomarkers. The concentrations of 
MCOCH, MONCH and MHNCH were measured by online solid phase extraction-high 
performance liquid chromatography-tandem mass spectrometry in urine collected in 2000 
(n=114), 2001 (n=57), 2007 (n=23), 2009 (n=118), 2011 (n=94) and 2012 (n=121) from 
convenience groups of anonymous U.S. adult volunteers with no known DINCH exposure. None 
of the DINCH metabolites were detected in samples collected in 2000 and 2001. Only one sample 
collected in 2007 had measureable concentrations of DINCH metabolites. The detection rate for 
all three metabolites increased from 2007 to 2012. The presence of oxidative metabolites of 
DINCH in urine suggests that these oxidative metabolites can be used as DINCH biomarkers for 
exposure assessment even at environmental exposure levels.
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1,2-Cyclohexane dicarboxylic acid, diisononyl ester is also known as di(isononyl) 
cyclohexane-1,2-dicarboxylate (DINCH). It is a complex mixture of linear and branched 
nine carbon dialkyl chain isomers of 1,2-cyclohexane dicarboxylic acid. DINCH is 
manufactured by catalytic hydrogenation of the aromatic ring of diisononyl phthalate 
(DINP) and commercialized as Hexamoll® DINCH. Since 2002, Hexamoll® DINCH has 
been used primarily as a plasticizer in polyvinylchloride plastics (up to 40%) and as an 
impact modifier in polystyrene (max 3%) in Europe (EFSA, 2006). DINCH is specifically 
used in human contact applications such as toys, medical devices, and food packaging 
(EFSA, 2006). In 2006, the European Food Safety Authority approved DINCH for a wide 
variety of food contact applications. DINCH is considered a safe alternative to di(2-
ethylhexyl) phthalate (DEHP) and DINP (Crespo et al., 2007), whose use has been restricted 
in the United States and some European countries because of concerns regarding potential 
human toxicity (Consumer Product Safety Commission, 2012; European Council for 
Plasticisers and Intermediates, 2012). Because of the growing global demand for alternative 
plasticizers, however, the production of DINCH is on the rise (BASF, 2011), and human 
exposure to DINCH is expected to occur.
Toxicological studies in animals have shown no evidence of developmental or reproductive 
toxicity or endocrine disruptive properties of DINCH (EFSA, 2006). But at high doses, 
thyroid hyperplasia and signs of renal toxicity have been reported in rats (EFSA, 2006). 
Several oxidative metabolites of DINCH have been identified in DINCH-dosed rats (Silva et 
al., 2012) and have been used as biomarkers of exposure to DINCH in humans (Koch et al., 
2013b; Schutze et al., 2012). In this study, we measured three of these oxidative metabolites: 
cyclohexane-1,2-dicarboxylic acid-monocarboxy isooctyl ester (MCOCH), 
cyclohexane-1,2-dicarboxylic acid-mono(oxo-isono-nyl) ester (MONCH), and 
cyclohexane-1,2-dicarboxylic acid-mono (hydroxy-isononyl) ester (MHNCH) (Fig. 1), in 
urine samples collected in 2000—2012 from convenience samples of U.S. adults with no 
known DINCH exposure. Because DINCH is used as a replacement plasticizer for DEHP 
and DINP applications, we also measured mono-(2-ethy-5-carboxyhexyl) phthalate 
(MECPP), a metabolite of DEHP, and mono-carboxyoctyl phthalate (MCOP), a metabolite 
of DINP. We hypothesized that we could use urinary concentrations of DINCH metabolites 
to assess the internal dose of DINCH in humans because urinary concentrations of 
nonpersistent chemicals or their metabolites have been used frequently as exposure 
biomarkers (Calafat et al., 2006; Needham et al., 2004; Sexton et al., 2004).
2. Materials and methods
2.1. Chemicals
Cyclohexane-1,2-dicarboxylic acid, mono hydroxyisononyl ester (MHNCH) and D4-
MHNCH were generous gifts from Dr. Holger Koch (University of Bochum, Germany). We 
purchased MECPP from Cambridge Isotope laboratories, Inc. (Andover, MA). 13C6-
MECPP, MCOP and 13C6-MCOP were purchased from CanSyn (Ontario, Canada). 
Acetonitrile (HPLC grade), water (HPLC grade), and methanol (99.8%, HPLC grade) were 
purchased from Honeywell Burdick & Jackson (Muskegon, MI). β-glucuronidase 
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(Escherichia coli-K12) was purchased from Roche Biomedical (Mannheim, Germany). All 
chemicals and reagents were used without further purification.
2.2. Analytical method
The analytical method for measuring DINCH and phthalate oxidative metabolites in urine, 
adapted from previous methods (Kato et al., 2005; Silva et al., 2007), is presented in detail 
in the Supporting information. Briefly, urine (0.1 mL) was spiked with an internal standard 
solution containing deuterium- or 13C-labeled analogs of the target metabolites and a 
buffered β-glucuronidase solution (E. coli-K12; 25 μL, pH 6.5/1 M), and incubated for a 
minimum of 120 min. The target analytes in the spiked urine were extracted using online 
solid phase extraction, chromatographically resolved by high performance liquid 
chromatography and detected using negative ion electrospray-ionization tandem mass 
spectrometry.
We did not attempt to separate the individual isomers of the DINCH or DINP metabolites. 
The isomers of the metabolites were eluted as undefined cluster of peaks (Fig. 2) and, for 
quantification, we integrated the whole area under the cluster of peaks (Silva et al., 2012, 
2006a). We quantified MONCH and MCOCH using the MHNCH calibration curve with D4-
MHNCH as the internal standard. Therefore, the reported concentrations for MONCH and 
MCOCH are only semi-quantitative in nature.
The identity of each metabolite peak in human urine was confirmed by matching the mass 
spectra obtained from DINCH-dosed rat urine (Fig. 2). The limits of detection (LODs) were 
0.4 ng/mL for the three DINCH metabolites and 0.2 ng/mL for MECPP and MCOP. The 
enzymatic hydrolysis step was omitted during sample preparation to measure the free 
metabolite concentrations. Subsets of samples with analyte concentrations at least >3*LOD 
were analyzed for free metabolite concentrations to increase the accuracy of the 
quantification of free metabolites. Samples with concentrations of DINCH metabolites 
ranging from LOD to 3*LOD were not analyzed for free metabolite species. Correlation 
analysis between metabolites were performed with levels >LOD.
2.3. Subjects
The urine samples analyzed for this study were archived samples (stored at -70 °C) collected 
anonymously in Atlanta, GA in 2000, 2001, 2007, 2009, 2011, and 2012 from a 
demographically diverse group of U.S. male and female adults with no known DINCH 
exposure. No personal information from the subjects was available. Samples were collected 
between 8:00 AM and 5:00 PM and were not necessarily first-morning voids. The Centers for 
Disease Control and Prevention (CDC) Internal Review Board approved the collection of 
the urine for the development and validation of analytical methods at CDC. A waiver of 
informed consent was requested under 45 CFR 46.116(d).
3. Results and discussion
In experimental animals, DINCH is less toxic than the high molecular weight phthalate 
plasticizers DEHP and DINP; thus DINCH is considered a versatile replacement for these 
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chemicals (EFSA, 2006). The potential health effects of DINCH in humans are currently 
unknown.
High molecular weight phthalates, such as DEHP and DINP, metabolize extensively before 
their excretion in urine (Koch and Calafat, 2009; Silva et al., 2006b). Some of these 
metabolites are unique for the parent chemical. Thus, some metabolites have been used as 
exposure biomarkers for DEHP (e.g., MECPP) and DINP (e.g., MCOP) (Koch et al., 2007; 
Silva et al., 2006a). Similarly, MHNCH, MCOCH, and MONCH are unique DINCH 
metabolites and as such can be used as biomarkers of DINCH exposure (Koch et al., 2013b; 
Silva et al., 2012).
In this study, the concentrations of MHNCH, MCOCH, and MONCH were measured in 
urine collected in 2000, 2001, 2007, 2009, 2011, and 2012 from convenience samples of 
U.S. male and female adults. We observed a wide range of concentrations of DINCH 
metabolites (Table 1). As expected, no DINCH metabolites were detected in urine collected 
in 2000 and 2001 because commercialization of DINCH started in Europe in 2002 (EFSA, 
2006). We detected DINCH metabolites in only one of the samples collected in 2007; the 
frequency of detection of DINCH metabolites increased to almost 10% in the samples 
collected in 2009 [MHNCH (8%), MCOCH (8%), MONCH (9%)] and to approximately 
15% in those collected in 2011 [MHNCH (13%), MCOCH (15%), MONCH (15%)]. In the 
samples collected in 2012, the detection frequency and magnitude of the concentrations 
were higher than in earlier years (Table 1). Because the detection rate was <50% for all three 
DINCH metabolites in all the years examined, we did not calculate geometric mean 
concentrations. Nevertheless, because all three metabolites of DINCH originated from a 
common precursor, their concentrations correlated well (r>0.8, Fig. 3).
Glucuronidation facilitates urinary excretion of xenobiotics (Silva et al., 2003). MONCH 
and MHNCH excreted fully glucuroni-dated (>99%). However, for MCOCH, the most polar 
of the three DINCH metabolites measured, the percentage excreted as the glucuronide 
conjugate was considerably lower (65%) than for the other metabolites.
The urinary concentrations of MHNCH, MONCH, and MCOCH were lower than the 
concentrations of the DEHP and DINP metabolites, MECPP and MCOP, respectively (Table 
1). Furthermore, the urinary concentrations of DINCH metabolites did not correlate with the 
urinary concentrations of either MECPP or MCOP (r<0.1, p>0.05). The lack of correlation 
between DINCH and phthalate metabolites in these subjects may indicate a difference 
between the sources of DINCH exposure and the two phthalates examined. Interestingly, the 
urinary concentrations of MCOP—a DINP metabolite—increased from 2000 to 2012 (Table 
1). In contrast, we observed a decline in the urinary concentrations of MECPP—a DEHP 
metabolite—during the same time period. Similarly, a German retrospective human 
biomonitor-ing study reported a decline in urinary concentrations of DEHP metabolites and 
an increase in urinary concentrations of DINP metabolites (Wittassek et al., 2007).
In a recent study, three human volunteers, who were orally administered DINCH, excreted 
23.7% of DINCH as the non-specific metabolite cyclohexane-1,2-dicarboxylic acid, 2% as 
MONCH, 10.7% as MHNCH and 2% as MCOCH (Koch et al., 2013a). These data suggest 
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that the metabolism of DINCH is different from that of phthalates because, unlike DINCH, 
DEHP and DINP mostly excrete as their oxidative metabolites (Koch and Calafat, 2009). 
Taken together, the findings above suggest that until 2012, environmental exposure to 
DINCH in the United States was likely lower than exposure to DEHP and DINP. Further, 
based on urinary concentrations of the respective metabolites, exposures to DINCH and 
DINP appear to have increased since the early 2000s, while exposure to DEHP may have 
decreased over the same period. For DINP and DEHP, data from the U.S. National Health 
and Nutrition Examination Survey (NHANES) also show similar trends in geometric mean 
concentrations of MCOP and MECPP (Table 2), (CDC, 2013), thus suggesting a parallel 
decrease in DEHP exposure and increase in DINP exposure.
In summary, we measured urinary concentrations of three oxidative metabolites of DINCH, 
a replacement plasticizer for DINP and DEHP, in urine collected in 2000—2012 from 
several convenience samplings of U.S. adults. The metabolites of DINCH were not detected 
in any of the samples collected in 2000—2001, which was before DINCH commercial 
introduction in 2002 in the European market. In contrast, the detection of DINCH 
metabolites increased in samples collected from 2007 to 2012. These data suggest that 
DINCH oxidative metabolites serve as effective biomarkers to assess environmental 
exposures to DINCH.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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DINCH metabolites proposed as biomarkers for exposure assessment in humans. Structures 
shown represent only one of the potential isomers.
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Chromatographic separation and mass spectra of three DINCH metabolites from human 
urine (this work) and DINCH-dosed rat urine (Silva et al., 2012). The identical retention 
times and the mass spectra of the metabolites between human urine and dosed rat urine 
confirm the positive identification of DINCH metabolites. Multiple isomers of each 
metabolite eluted with close retention times.
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Correlation analyses of urinary concentrations of DINCH metabolites. r represents the 
Pearson correlation coefficient. Solid line represents the regression line.
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